Canine generalised demodicosis (CGD) is a challenging disease to treat effectively. Inactivated parapoxvirus ovis (iPPVO) could help to accelerate treatment with acaricidial therapy by altering the immune response. This study was designed to investigate the effects of treating CGD with amitraz plus iPPVO in terms of clinical outcomes and blood parameters. The study involved 16 dogs ranging in age from eight months to six years and weighing between 10 and 40 kg. Eight dogs were treated with amitraz and eight with amitraz plus iPPVO. Biochemical analysis of whole blood and serum, including serum C reactive protein (CRP) and serum amyloid A (SAA), was performed. Skin scrapings were conducted on days 0, 10, 40, 80 and 120 of treatment, and mite numbers were recorded. Clinical remission was determined according to mite numbers and clinical scores. The difference in mean whole remission days between the amitraz group (104.3 days) and the amitraz+iPPVO group (84.5 days) was statistically significant (P<0.05). Mean clinical scores were also significantly better in the amitraz+iPPVO (5.60) group when compared with the amitraz group (7.65). No adverse reactions were observed in either group. In view of these findings, the use of iPPVO in conjunction with amitraz can be recommended for treating CGD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/vr.102226 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
TLR9-Dependent Activation by Inactivated Parapoxvirus Ovis in Murine Bone Marrow-Derived Dendritic Cells Is Associated with Specific Strain-Dependent Dendritic Cell Subsets.
J Innate Immun
July 2024
Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Article Synopsis
- Inactivated parapoxvirus ovis (iPPVO) shows potential as a therapeutic agent by strongly affecting innate immune cells, but its signaling pathways remain poorly understood.
- The study analyzed how different types of dendritic cells (DCs) in mice responded to iPPVO through various methods, including flow cytometry and Western blotting.
- Results indicated that while certain DCs matured and produced cytokines in response to iPPVO, the signaling pathways involved varied; cDCs were activated independently of Toll-like receptor 9 (TLR9), while the activation of pDCs was partially reliant on TLR9, suggesting other pathways also play a role in the immune response.
Orf, a Human Parapoxvirus Infection.
Adv Exp Med Biol
May 2024
Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria.
Article Synopsis
- Parapoxvirus infections are often overlooked zoonoses, causing oral lesions in ruminants and can be transmitted directly or indirectly to humans through contact with infected animals or contaminated items.
- The virus shows no significant symptoms in many infected animals, complicating detection and emphasizing the need for a "One Health" approach to address both human and veterinary health.
- In immunocompetent humans, the lesions can self-resolve within 2 months, while immunocompromised individuals may require medical interventions such as antiviral treatments or surgery.
Orf virus as an adjuvant enhances the immune response to a PCV2 subunit vaccine.
Vet Microbiol
June 2024
National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China; The Key Laboratory of Preventive Veterinary Medicine in Hubei Province, Cooperative Innovation Center for Sustainable Pig Production, Wuhan 430070, China. Electronic address:
Orf virus (ORFV), a member of the genus Parapoxvirus, possesses an excellent immune activation capability, which makes it a promising immunomodulation agent. In this study, we evaluated ORFV as a novel adjuvant to enhance the immune response of mice to a subunit vaccine using porcine circovirus type 2 (PCV2) capsid (Cap) protein as a model. Our results showed that both inactivated and live attenuated ORFV activated mouse bone marrow-derived dendritic cells and increased expression of immune-related cytokines interleukin (IL)-1β, IL-6, and TNF-α.
View Article and Find Full Text PDFStability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus.
Vaccine
July 2023
Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen (THM), Wiesenstr.14, 35390 Giessen, Germany. Electronic address:
A promising new vaccine platform is based on the Orf virus, a viral vector of the genus Parapoxvirus, which is currently being tested in phase I clinical trials. The application as a vaccine platform mandates a well-characterised, robust, and efficient production process. To identify critical process parameters in the production process affecting the virus' infectivity, the Orf virus was subjected to forced degradation studies, including thermal, pH, chemical, and mechanical stress conditions.
View Article and Find Full Text PDFAn Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.
Viruses
April 2023
Department of Population Medicine and Diagnostic Sciences, Animal Health Diagnostic Center, College of Veterinary Medicine, Cornell University, Ithaca, NY 14850, USA.
Influenza A viruses (IAV-S) belonging to the H1 subtype are endemic in swine worldwide. Antigenic drift and antigenic shift lead to a substantial antigenic diversity in circulating IAV-S strains. As a result, the most commonly used vaccines based on whole inactivated viruses (WIVs) provide low protection against divergent H1 strains due to the mismatch between the vaccine virus strain and the circulating one.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!